MED12 and leiomyoma: Interestingly, previous reports showed slightly higher frequency of MED12 mutations in uLMS, a difference that could be linked to the lower number of cases analyzed [14,17] but maybe also to the random selection of the subset of tumors arising from previous leiomyomas, whose clinical features still have to be uncovered.